USANA Health Sciences has faced significant regulatory scrutiny over product claims and deceptive marketing practices, resulting in formal investigations and enforcement action by federal agencies. In 2023, Truth in Advertising (TINA.org) notified USANA that the company had used unsubstantiated disease-treatment claims to market its nutritional products and atypical income claims to market its business opportunity model. Following this investigation, USANA removed deceptive marketing claims from the internet, but the regulatory action underscores ongoing concerns about how the company markets its products and income potential to consumers and distributors.
Unlike a traditional class action settlement with defined damages, the USANA situation represents an example of regulatory enforcement and consumer awareness that may lead to future litigation if consumers can prove direct financial harm from reliance on false product claims. The regulatory issues at USANA extend beyond product claims to include broader deceptive marketing practices. The Federal Trade Commission formally notified USANA of penalty offenses related to deceptive income claims and violations of endorsement disclosure rules, meaning the company must comply or face additional enforcement action and potential penalties. This regulatory history is important for consumers to understand because it reveals that claims made by USANA, its distributors, and its sponsored athletes may not be trustworthy and could reflect misleading marketing rather than substantiated product benefits.
Table of Contents
- What Regulatory Issues Has USANA Faced Over Product Claims?
- What Unsubstantiated Claims Did USANA Make About Its Products?
- How Did USANA Violate FTC Endorsement and Disclosure Rules?
- How Can Consumers Identify Deceptive Product Claims From MLM Companies?
- What Does USANA’s Regulatory History Reveal About Its Marketing Practices?
- Is There Currently a Class Action Settlement for USANA Product Claims?
- How Are Regulatory Agencies Addressing MLM Marketing Claims?
What Regulatory Issues Has USANA Faced Over Product Claims?
USANA’s product marketing has drawn scrutiny from Truth in Advertising and the Federal Trade Commission for making disease-treatment claims without scientific substantiation. The 2023 TINA.org investigation, which examined 100 multi-level marketing companies, specifically identified USANA as making unsubstantiated claims that its nutritional supplements could treat, cure, or prevent diseases. These types of claims violate FDA regulations, which prohibit dietary supplement companies from claiming that their products treat medical conditions. USANA’s removal of these deceptive claims following the TINA.org notification confirms that the company had indeed been using language and marketing strategies that could mislead consumers into believing its products were pharmaceutical-grade treatments rather than dietary supplements. The FTC’s formal notice to USANA regarding deceptive income claims represents another layer of regulatory concern. In multi-level marketing companies, income claims are particularly problematic because distributors often exaggerate earning potential to recruit new participants.
The FTC has issued formal notices to USANA warning the company about using income representations without proper substantiation and without disclosing that most participants earn little to no money. This is a critical distinction: when a company like USANA makes income claims without properly disclaiming the actual income experience of the average participant, it violates FTC regulations and can cause financial harm to consumers who make business decisions based on inflated expectations. The removal of deceptive marketing claims by USANA after regulatory pressure demonstrates that the company had been engaging in practices it knew—or should have known—were not compliant with federal law. Rather than fighting the TINA.org findings, USANA quietly removed the problematic language from its marketing materials. This pattern is concerning because it suggests the company was testing the boundaries of what it could claim, and only when confronted by advocacy organizations did it correct course. For consumers who relied on product claims made before removal, this creates a potential legal argument that they were deceived.
What Unsubstantiated Claims Did USANA Make About Its Products?
While specific product examples from USANA’s removed marketing materials are not publicly itemized, the regulatory findings indicate that the company made disease-treatment and health-condition claims across its product line. Dietary supplement companies commonly make claims like “supports immune function” or “promotes healthy joints,” which are legal claims if properly qualified. However, claims that a supplement “treats” arthritis, “cures” joint pain, or “prevents” disease cross the line into drug claims and require FDA approval that USANA’s products do not have.
The distinction is subtle but legally significant: you can claim a supplement “supports” health, but you cannot claim it treats a disease. The limitation of relying on regulatory action rather than a class action settlement is that individual consumers may have difficulty proving they relied on specific false claims and suffered direct financial damages. Regulatory investigations establish that deceptive practices occurred, but they do not necessarily quantify consumer harm or establish a mechanism for compensation. This is why consumers who believe they were specifically harmed by USANA’s false claims might need to pursue private litigation or investigate whether a class action is being formed around these issues.
How Did USANA Violate FTC Endorsement and Disclosure Rules?
USANA sponsored athletes—including Olympic wrestler Sarah Hildebrandt and boxer Austin Trout—who failed to properly disclose their material relationship to the company on social media, in direct violation of FTC guidelines. The FTC requires that endorsers clearly and conspicuously disclose any material connection to a company they promote, meaning if an athlete is paid or receives products in exchange for endorsement, that relationship must be explicitly stated. When USANA-sponsored athletes posted about USANA products on Instagram, TikTok, or other social platforms without proper disclosure hashtags like #ad or #sponsored, they made it appear that their endorsements were genuine personal testimonials rather than paid promotions. This is deceptive to consumers who see a trusted athlete promoting a product and assume the recommendation is unbiased.
The endorsement disclosure violations are particularly problematic in the context of a multi-level marketing company because mlm athletes often have dual incentives: they receive direct compensation from USANA as spokespersons, but they may also earn money by recruiting others to buy products. This creates a situation where an athlete’s endorsement serves multiple purposes—promoting the company’s brand and simultaneously recruiting participants into its income opportunity. Without clear disclosure, consumers cannot evaluate whether the endorsement is trustworthy. A wrestler promoting USANA products who also profits from USANA recruitment has a financial incentive to make products sound more effective than they might actually be.
How Can Consumers Identify Deceptive Product Claims From MLM Companies?
Consumers should be skeptical of disease-treatment or health-condition claims made by any dietary supplement company, particularly MLM companies like USANA. If a company claims its products “treat,” “cure,” “prevent,” or “diagnose” any disease or medical condition, that is a red flag. Legal supplement claims use language like “supports,” “promotes,” “maintains,” or “helps with,” which do not imply medical benefit. Additionally, if a supplement company claims its products have pharmaceutical-level efficacy without FDA approval, that claim is almost certainly false. USANA’s removal of deceptive claims after regulatory pressure is a cautionary tale: if a company is willing to make unsupported health claims, it may also be willing to overstate product quality, purity, or potency.
Another warning sign is income claims made by distributors or the company itself. MLM companies and their distributors often cite examples of high-earning participants without disclosing that these are exceptions. If an USANA distributor or USANA’s marketing materials claim that participants can earn $5,000 per month or replace their job income, demand to see substantiated income disclosure statements. By federal law, legitimate MLM companies must provide income disclosure statements showing what the average participant actually earns. If a company cannot or will not provide this data, treat income claims with extreme skepticism. The FTC’s warning to USANA about deceptive income claims suggests the company was not properly qualifying how rarely high earnings are achieved.
What Does USANA’s Regulatory History Reveal About Its Marketing Practices?
USANA’s 2023 regulatory issues did not emerge in a vacuum; the company has a documented history of marketing controversies. The 2017-2018 federal securities class action, filed on February 13, 2017, alleged Foreign Corrupt Practices Act violations and accounting irregularities before being dismissed with prejudice on October 17, 2018. While this securities litigation was not directly about product claims, it revealed that USANA faced scrutiny for how it represented its business practices and financial performance to investors. The fact that a securities case was settled and dismissed suggests that USANA reached some form of agreement with plaintiffs, though the company did not admit wrongdoing.
The combination of securities litigation and product-marketing regulatory action demonstrates a pattern of USANA pushing boundaries in multiple areas—financial claims to investors, income claims to distributors, and product claims to consumers. This pattern suggests that aggressive or misleading marketing may be part of the company’s business model rather than isolated incidents. A limitation of the 2023 regulatory action is that it did not result in a public settlement with consumer compensation, as a class action lawsuit would. Instead, USANA corrected its marketing materials, but consumers who purchased products based on false claims prior to removal may have no obvious avenue for recovery without pursuing independent legal action.
Is There Currently a Class Action Settlement for USANA Product Claims?
Based on available public records, there is no active or settled class action specifically focused on USANA product claims with defined settlement amounts or consumer compensation as of 2024-2026. The regulatory action by TINA.org and the FTC’s formal notices are enforcement actions, not class action settlements. However, the regulatory findings establish that USANA made deceptive product claims, which creates a foundation for potential future litigation. If a consumer or group of consumers suffered direct financial harm by purchasing USANA products based on false claims, they could potentially pursue a class action lawsuit.
Any future class action would need to demonstrate that USANA made specific false claims, that consumers relied on those claims, and that consumers suffered quantifiable damages (such as overpaying for products that did not deliver promised benefits). Consumers who believe they were harmed by USANA’s deceptive claims should document their purchases, save any marketing materials they relied on, and consult with a class action attorney. An attorney can determine whether individual claims or a class action may be viable. The absence of a current class action settlement does not mean USANA’s practices were legal or acceptable; it simply means consumers have not yet successfully brought a unified lawsuit with court approval and settlement authority.
How Are Regulatory Agencies Addressing MLM Marketing Claims?
The FTC and other regulatory agencies have intensified scrutiny of MLM companies’ product claims and income representations over the past several years. USANA’s 2023 regulatory actions reflect this broader trend toward enforcement. The FTC has issued formal notices to multiple MLM companies warning about deceptive income claims, unsubstantiated product claims, and endorsement disclosure violations. This enforcement trend suggests that consumers should be increasingly vigilant about MLM marketing and skeptical of claims that seem too good to be true, whether those claims involve product efficacy or earning potential.
Going forward, expect regulatory agencies to continue monitoring MLM companies’ online marketing, social media endorsements, and income claims. The USANA case demonstrates that even relatively well-known companies with decades of history can face serious regulatory enforcement for marketing practices. Consumers and potential participants should be aware that regulatory action may follow the discovery of deceptive claims, but by that time, many consumers may already have been harmed. The most protective approach is to scrutinize claims from MLM companies skeptically before making purchasing or recruitment decisions.
You Might Also Like
- Shaklee Product Health Claims Class Action
- Young Living Essential Oils Health Claims Class Action
- Thrive Le-Vel Health Claims Class Action
Open Settlements You Can Claim Now
Browse current class action settlements accepting claims — several require no proof of purchase: